Literature DB >> 12704579

Hyperfiltration and glomerulosclerosis.

Thomas H Hostetter1.   

Abstract

Nearly 70 years ago, the association between reduction in renal mass and subsequent glomerular injury was established. Later the pathologic changes were attributed to adaptive hemodynamic changes in the residual nephrons. This relationship seems to exist in a number of experimental animal species, as well as humans. Among the various hemodynamic changes that occur within residual nephrons, the increase in glomerular pressure is the most important in generating subsequent pathologic changes. The renin-angiotensin-aldosterone system seems to contribute to the intrarenal pressure. Both angiotensin and aldosterone participate. Increases in glomerular pressure appear to act on the mesangial compartment causing it to increase its cell number and matrix volume. Deleterious interactions between higher pressures, increased capillary volume, and a relatively fixed podocyte number also appear to contribute to the sclerotic process. Endothelial cell changes occur perhaps in response to direct hemodynamic stimuli, but their role in the sclerotic process is less clear than those of mesangial and glomerular epithelial cells. Copyright 2003 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2003        PMID: 12704579     DOI: 10.1053/anep.2003.50017

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  61 in total

1.  Vasculature and kidney complications in sickle cell disease.

Authors:  Karl A Nath; Zvonimir S Katusic
Journal:  J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 10.121

Review 2.  Current insights and new perspectives on the roles of hyperglucagonemia in non-insulin-dependent type 2 diabetes.

Authors:  Xiao C Li; Jia L Zhuo
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

3.  Glucagon receptor-mediated extracellular signal-regulated kinase 1/2 phosphorylation in rat mesangial cells: role of protein kinase A and phospholipase C.

Authors:  Xiao C Li; Oscar A Carretero; Yuan Shao; Jia L Zhuo
Journal:  Hypertension       Date:  2006-01-03       Impact factor: 10.190

Review 4.  Sickle cell disease: renal manifestations and mechanisms.

Authors:  Karl A Nath; Robert P Hebbel
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

5.  Bone marrow-derived progenitor cells do not contribute to podocyte turnover in the puromycin aminoglycoside and renal ablation models in rats.

Authors:  Catherine Meyer-Schwesinger; Claudia Lange; Verena Bröcker; Putri Andina Agustian; Putri Andina Agustian; Ulrich Lehmann; Annette Raabe; Martina Brinkmeyer; Eiji Kobayashi; Mario Schiffer; Guntram Büsche; Hans H Kreipe; Friedrich Thaiss; Jan U Becker
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

6.  Idiopathic nodular glomerulosclerosis in Chinese patients: a clinicopathologic study of 20 cases.

Authors:  Jun Wu; Shengqiang Yu; Vickram Tejwani; Michael Mao; Angela K Muriithi; Chaoyang Ye; Xuezhi Zhao; Hongchen Gu; Changlin Mei; Qi Qian
Journal:  Clin Exp Nephrol       Date:  2014-01-10       Impact factor: 2.801

7.  Podocyte injury damages other podocytes.

Authors:  Taiji Matsusaka; Eric Sandgren; Ayumi Shintani; Valentina Kon; Ira Pastan; Agnes B Fogo; Iekuni Ichikawa
Journal:  J Am Soc Nephrol       Date:  2011-06-30       Impact factor: 10.121

Review 8.  Does significant renal ablation truly and invariably lead to hyperfiltration and progressive chronic kidney disease?

Authors:  Andrew Wang; Ramin Sam
Journal:  Clin Exp Nephrol       Date:  2016-10-13       Impact factor: 2.801

9.  PRAS40 acts as a nodal regulator of high glucose-induced TORC1 activation in glomerular mesangial cell hypertrophy.

Authors:  Nirmalya Dey; Nandini Ghosh-Choudhury; Falguni Das; Xiaonan Li; Balachandar Venkatesan; Jeffrey L Barnes; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

10.  Clinicopathological characteristics of patients with immunoglobulin A nephropathy showing acute exacerbations after favorable long-term clinical courses.

Authors:  Mai Tanaka; Yoichi Miyazaki; Kentaro Koike; Hiroyuki Ueda; Nobuo Tsuboi; Keita Hirano; Hideo Okonogi; Makoto Ogura; Tetsuya Kawamura; Takashi Yokoo
Journal:  Clin Exp Nephrol       Date:  2015-08-20       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.